These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35338518)

  • 1. Role of NIMA-related kinase 2 in lung cancer: Mechanisms and therapeutic prospects.
    Shah D; Joshi M; Patel BM
    Fundam Clin Pharmacol; 2022 Oct; 36(5):766-776. PubMed ID: 35338518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Catenin is a Nek2 substrate involved in centrosome separation.
    Bahmanyar S; Kaplan DD; Deluca JG; Giddings TH; O'Toole ET; Winey M; Salmon ED; Casey PJ; Nelson WJ; Barth AI
    Genes Dev; 2008 Jan; 22(1):91-105. PubMed ID: 18086858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer.
    Liu Q; Hirohashi Y; Du X; Greene MI; Wang Q
    Exp Mol Pathol; 2010 Apr; 88(2):225-33. PubMed ID: 20034488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cep68 can be regulated by Nek2 and SCF complex.
    Man X; Megraw TL; Lim YP
    Eur J Cell Biol; 2015; 94(3-4):162-72. PubMed ID: 25704143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
    Mbom BC; Siemers KA; Ostrowski MA; Nelson WJ; Barth AI
    Mol Biol Cell; 2014 Apr; 25(7):977-91. PubMed ID: 24501426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NEK2 as a promising therapeutic approach for cancer treatment.
    Fang Y; Zhang X
    Cell Cycle; 2016; 15(7):895-907. PubMed ID: 27019372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells.
    Rivera-Rivera Y; Marina M; Jusino S; Lee M; Velázquez JV; Chardón-Colón C; Vargas G; Padmanabhan J; Chellappan SP; Saavedra HI
    Sci Rep; 2021 Apr; 11(1):9016. PubMed ID: 33907253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
    Chen C; Peng S; Li P; Ma L; Gan X
    Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.
    Xu T; Zeng Y; Shi L; Yang Q; Chen Y; Wu G; Li G; Xu S
    J Exp Clin Cancer Res; 2020 Sep; 39(1):183. PubMed ID: 32907622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.
    Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y
    J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEK2 plays an essential role in porcine embryonic development by maintaining mitotic division and DNA damage response via the Wnt/β-catenin signalling pathway.
    Jeon SB; Jeong PS; Kang HG; Kim MJ; Yun JH; Lim KS; Song BS; Kim SU; Cho SK; Sim BW
    Cell Prolif; 2024 Aug; 57(8):e13626. PubMed ID: 38426218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.
    Lee J; Gollahon L
    Cell Cycle; 2013 Dec; 12(23):3599-614. PubMed ID: 24091727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nek2 kinase in chromosome instability and cancer.
    Hayward DG; Fry AM
    Cancer Lett; 2006 Jun; 237(2):155-66. PubMed ID: 16084011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival.
    Neal CP; Fry AM; Moreman C; McGregor A; Garcea G; Berry DP; Manson MM
    J Surg Oncol; 2014 Dec; 110(7):828-38. PubMed ID: 25043295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.
    McCrury M; Swafford K; Shuttleworth SL; Mehdi SH; Acharya B; Saha D; Naceanceno K; Byrum SD; Storey AJ; Xu YZ; Doshier C; Patel V; Post GR; De Loose A; Rodriguez A; Shultz LD; Zhan F; Yoon D; Frett B; Kendrick S
    Mol Cancer Ther; 2024 Mar; 23(3):316-329. PubMed ID: 37816504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2.
    Zhao D; Han W; Liu X; Cui D; Chen Y
    Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2.
    Fry AM; Mayor T; Meraldi P; Stierhof YD; Tanaka K; Nigg EA
    J Cell Biol; 1998 Jun; 141(7):1563-74. PubMed ID: 9647649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators.
    Fry AM; Meraldi P; Nigg EA
    EMBO J; 1998 Jan; 17(2):470-81. PubMed ID: 9430639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.
    Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH
    Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
    Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
    Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.